★★

OLIPASS

Olipass Faces Additional Delisting Reason; Awaiting Litigation Outcome


  • Olipass recorded Q1 2026 sales under KRW 300 million, triggering an additional reason for delisting review
  • Delisting was already decided on Oct 14, 2025, but suspended via injunction, halting settlement trading
  • Subsequent procedures will follow based on litigation outcome

KOSDAQ Filing Information


  • Filing: Other Market Notice (Non-Progression Of Procedures Related To Addition Of Reasons For Substantive Review Of Listing Eligibility)
  • Company: OLIPASS (244460)
  • Submission: KOSDAQ Market Division
  • Receipt: 05-15-2026
  • Under KRX KOSDAQ Market Division